Fig. 3: Validation of SSP models for clinical markers in the independent population-based test set of early breast cancer. | npj Breast Cancer

Fig. 3: Validation of SSP models for clinical markers in the independent population-based test set of early breast cancer.

From: RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

Fig. 3: Validation of SSP models for clinical markers in the independent population-based test set of early breast cancer.

Agreement chart and confusion matrix comparing the SSP classifications (x-axis/columns) with clinical histopathology status (y-axis/rows) for a ER status, b PR status, c HER2 status using a general SSP model, d HER2 status using a SSP model specific for ER status, e Ki67-status, f NHG.

Back to article page